Cargando…
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm
[Image: see text] We have previously shown that the thermolabile, cavity-creating p53 cancer mutant Y220C can be reactivated by small-molecule stabilizers. In our ongoing efforts to unearth druggable variants of the p53 mutome, we have now analyzed the effects of other cancer-associated mutations at...
Autores principales: | Bauer, Matthias R., Krämer, Andreas, Settanni, Giovanni, Jones, Rhiannon N., Ni, Xiaomin, Khan Tareque, Raysa, Fersht, Alan R., Spencer, John, Joerger, Andreas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307883/ https://www.ncbi.nlm.nih.gov/pubmed/31990523 http://dx.doi.org/10.1021/acschembio.9b00748 |
Ejemplares similares
-
A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C
por: Bauer, Matthias R, et al.
Publicado: (2019) -
Harnessing Fluorine–Sulfur Contacts and Multipolar
Interactions for the Design of p53 Mutant Y220C Rescue Drugs
por: Bauer, Matthias R., et al.
Publicado: (2016) -
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
por: Baud, Matthias G.J., et al.
Publicado: (2018) -
Small molecule induced reactivation of mutant p53 in cancer cells
por: Liu, Xiangrui, et al.
Publicado: (2013) -
Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53
por: Joerger, Andreas C., et al.
Publicado: (2015)